Skip to content

Effect of Different Concentrations Atropine on Visual Function and Visual Quality in Young Adults

Effect of Different Concentrations Atropine on Visual Function and Visual Quality in Young Adults

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063791
Enrollment
Unknown
Registered
2022-09-16
Start date
2022-09-16
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Group 1:0.05% atropine eye drop
Group 2:0.01% atropine eye drop

Sponsors

Eye Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 30 years; 2. Spherical refractive error of -0.50D~-5.75Din each eye; 3. Astigmatism of not more than 1.00 D; 4. Anisometropia of less than 1.50 D; 4. Best-corrected visual acuity of 0.00 logMAR or better in each eye.

Exclusion criteria

Exclusion criteria: 1. Continuous use of myopia prevention and control products for more than 1 month in the past 1 year; 2. History of eye surgery; 3. History of eye diseases (such as amblyopia, strabismus, glaucoma, etc.); 4. Atropine contraindications (such as: history of atropine allergy, intraocular pressure >= 21 mmHg or interocular pressure difference >= 5 mmHg, peripheral anterior chamber depth <= 1/4 corneal thickness); 5. History of allergy to sodium fluorescein, tear film breakup time < 5 s; 6. Poor general health (such as heart or respiratory disease).

Design outcomes

Primary

MeasureTime frame
accommodative amplitude;accommodative response;accommodation microfluctuations;asthenopia questionnaire;contrast sensitivity;near contrast visual acuity;objective scattering index;predictive visual acuity;tear breakup time;tear meniscus area;mean objective scattering index;standard deviation objective scattering index;

Secondary

MeasureTime frame
pseudo accommodation;bulbar redness;meiboscore;pupil diameter;lateral phoria;positive fusion vergence;negative fusion vergence;positive relative accommodation;negative relative accommodation;accommodative facility;nearwork induced transient myopia;

Countries

China

Contacts

Public ContactJinhua Bao

Eye Hospital of Wenzhou Medical University

baojessie@163.com+86 13777762827

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026